168 related articles for article (PubMed ID: 22530898)
1. Synthesis and β-glucuronidase inhibitory potential of benzimidazole derivatives.
Khan KM; Khan M; Ambreen N; Rahim F; Naureen S; Perveen S; Choudhary MI; Voelter W
Med Chem; 2012 May; 8(3):421-7. PubMed ID: 22530898
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of benzimidazole derivatives as potent β-glucuronidase inhibitors.
Taha M; Ismail NH; Imran S; Selvaraj M; Rashwan H; Farhanah FU; Rahim F; Kesavanarayanan KS; Ali M
Bioorg Chem; 2015 Aug; 61():36-44. PubMed ID: 26073618
[TBL] [Abstract][Full Text] [Related]
3. Novel 2,5-disubtituted-1,3,4-oxadiazoles with benzimidazole backbone: a new class of β-glucuronidase inhibitors and in silico studies.
Zawawi NK; Taha M; Ahmat N; Wadood A; Ismail NH; Rahim F; Ali M; Abdullah N; Khan KM
Bioorg Med Chem; 2015 Jul; 23(13):3119-25. PubMed ID: 26001340
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of bisindole as potent β-glucuronidase inhibitors: synthesis and in silico based studies.
Khan KM; Rahim F; Wadood A; Taha M; Khan M; Naureen S; Ambreen N; Hussain S; Perveen S; Choudhary MI
Bioorg Med Chem Lett; 2014 Apr; 24(7):1825-9. PubMed ID: 24602903
[TBL] [Abstract][Full Text] [Related]
5. Thiadiazole derivatives as New Class of β-glucuronidase inhibitors.
Salar U; Taha M; Ismail NH; Khan KM; Imran S; Perveen S; Wadood A; Riaz M
Bioorg Med Chem; 2016 Apr; 24(8):1909-18. PubMed ID: 26994638
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, in vitro β-glucuronidase inhibitory potential and molecular docking studies of quinolines.
Bano B; Arshia ; Khan KM; Kanwal ; Fatima B; Taha M; Ismail NH; Wadood A; Ghufran M; Perveen S
Eur J Med Chem; 2017 Oct; 139():849-864. PubMed ID: 28865280
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and β-glucuronidase inhibitory activity of 2-arylquinazolin-4(3H)-ones.
Khan KM; Saad SM; Shaikh NN; Hussain S; Fakhri MI; Perveen S; Taha M; Choudhary MI
Bioorg Med Chem; 2014 Jul; 22(13):3449-54. PubMed ID: 24844756
[TBL] [Abstract][Full Text] [Related]
8. Biology-oriented drug synthesis (BIODS): In vitro β-glucuronidase inhibitory and in silico studies on 2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl aryl carboxylate derivatives.
Salar U; Khan KM; Taha M; Ismail NH; Ali B; Qurat-Ul-Ain ; Perveen S; Ghufran M; Wadood A
Eur J Med Chem; 2017 Jan; 125():1289-1299. PubMed ID: 27886546
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of bis-indolylmethanes as new potential inhibitors of β-glucuronidase and their molecular docking studies.
Taha M; Ullah H; Al Muqarrabun LMR; Khan MN; Rahim F; Ahmat N; Ali M; Perveen S
Eur J Med Chem; 2018 Jan; 143():1757-1767. PubMed ID: 29133042
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and in silico studies of novel sulfonamides having oxadiazole ring: As β-glucuronidase inhibitors.
Taha M; Baharudin MS; Ismail NH; Selvaraj M; Salar U; Alkadi KA; Khan KM
Bioorg Chem; 2017 Apr; 71():86-96. PubMed ID: 28160943
[TBL] [Abstract][Full Text] [Related]
11. Design, molecular docking and synthesis of novel 5,6-dichloro-2-methyl-1H-benzimidazole derivatives as potential urease enzyme inhibitors.
Menteşe E; Emirik M; Sökmen BB
Bioorg Chem; 2019 May; 86():151-158. PubMed ID: 30710848
[TBL] [Abstract][Full Text] [Related]
12. β-glucuronidase inhibitory studies on coumarin derivatives.
Khan KM; Fakhri MI; Shaikh NN; Saad SM; Hussain S; Perveen S; Choudhary MI
Med Chem; 2014; 10(8):778-82. PubMed ID: 24611780
[TBL] [Abstract][Full Text] [Related]
13. 2,5-Disubstituted thiadiazoles as potent β-glucuronidase inhibitors; Synthesis, in vitro and in silico studies.
Taha M; Barak Almandil N; Rashid U; Ali M; Ibrahim M; Gollapalli M; Mosaddik A; Mohammed Khan K
Bioorg Chem; 2019 Oct; 91():103126. PubMed ID: 31349116
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and molecular docking study of some 5,6-dichloro-2-cyclopropyl-1H-benzimidazole derivatives bearing triazole, oxadiazole, and imine functionalities as potent inhibitors of urease.
Menteşe E; Bektaş H; Sokmen BB; Emirik M; Çakır D; Kahveci B
Bioorg Med Chem Lett; 2017 Jul; 27(13):3014-3018. PubMed ID: 28526368
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of (benzimidazol-2-yl)aniline derivatives as glycogen phosphorylase inhibitors.
Galal SA; Khattab M; Andreadaki F; Chrysina ED; Praly JP; Ragab FAF; El Diwani HI
Bioorg Med Chem; 2016 Nov; 24(21):5423-5430. PubMed ID: 27624527
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, in vitro urease inhibitory potential and molecular docking study of Benzimidazole analogues.
Zaman K; Rahim F; Taha M; Ullah H; Wadood A; Nawaz M; Khan F; Wahab Z; Shah SAA; Rehman AU; Kawde AN; Gollapalli M
Bioorg Chem; 2019 Aug; 89():103024. PubMed ID: 31176853
[TBL] [Abstract][Full Text] [Related]
17. 5-Bromo-2-aryl benzimidazole derivatives as non-cytotoxic potential dual inhibitors of α-glucosidase and urease enzymes.
Arshad T; Khan KM; Rasool N; Salar U; Hussain S; Asghar H; Ashraf M; Wadood A; Riaz M; Perveen S; Taha M; Ismail NH
Bioorg Chem; 2017 Jun; 72():21-31. PubMed ID: 28346872
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, in vitro β-glucuronidase inhibitory activity and in silico studies of novel (E)-4-Aryl-2-(2-(pyren-1-ylmethylene)hydrazinyl)thiazoles.
Salar U; Khan KM; Syed S; Taha M; Ali F; Ismail NH; Perveen S; Wadood A; Ghufran M
Bioorg Chem; 2017 Feb; 70():199-209. PubMed ID: 28069264
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of novel inhibitors of β-glucuronidase based on benzothiazole skeleton and study of their binding affinity by molecular docking.
Khan KM; Rahim F; Halim SA; Taha M; Khan M; Perveen S; Zaheer-Ul-Haq ; Mesaik MA; Iqbal Choudhary M
Bioorg Med Chem; 2011 Jul; 19(14):4286-94. PubMed ID: 21684753
[TBL] [Abstract][Full Text] [Related]
20. Indole and benzimidazole derivatives as steroid 5alpha-reductase inhibitors in the rat prostate.
Takami H; Kishibayashi N; Ishii A; Kumazawa T
Bioorg Med Chem; 1998 Dec; 6(12):2441-8. PubMed ID: 9925300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
